Literature DB >> 567372

Phenylalanine depletion for the management of phenylketonuria: use of enzyme reactors with immobilized enzymes.

C M Ambrus, J L Ambrus, C Horvath, H Pedersen, S Sharma, C Kant, E Mirand, R Guthrie, T Paul.   

Abstract

Multitubular enzyme reactors with immobilized phenylalanine ammonia lyase were tested in vitro and in vivo for depletion of phenylalanine in circulating blood. Sustained reduction of phenylalanine was achieved in less than 30 minutes. A 50% decrease of phenylalanine was obtained with a 2-hour application of enzyme reactors and was maintained for more than 2 days. Similar enzyme reactors have therapeutic potential for temporary management of phenylketonuric patients when their circulating phenylalanine becomes exceedingly high because of infection, fever, or pregnancy.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 567372     DOI: 10.1126/science.567372

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  12 in total

Review 1.  Phenylketonuria: old disease, new approach to treatment.

Authors:  H L Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

2.  Clinical therapeutics for phenylketonuria.

Authors:  Jaspreet Singh Kochhar; Sui Yung Chan; Pei Shi Ong; Lifeng Kang
Journal:  Drug Deliv Transl Res       Date:  2012-08       Impact factor: 4.617

3.  Anisotropic membranes with carboxypeptidase G1.

Authors:  A M Pitt; S M Cramer; A B Czernicki; K Kalghatgi; C Horvath; B A Solomon
Journal:  Appl Biochem Biotechnol       Date:  1983-02       Impact factor: 2.926

4.  An immobilized microbial heparinase for blood deheparinization.

Authors:  R J Linhardt; C L Cooney; D Tapper; C A Zannetos; A K Larsen; R Langer
Journal:  Appl Biochem Biotechnol       Date:  1984-02       Impact factor: 2.926

5.  Pharmacokinetic characterization of extracorporeal therapy.

Authors:  H Pedersen; C Horváth
Journal:  J Pharmacokinet Biopharm       Date:  1982-08

6.  Mean-field model of immobilized enzymes embedded in a grafted polymer layer.

Authors:  Yevgeny Moskovitz; Simcha Srebnik
Journal:  Biophys J       Date:  2005-04-01       Impact factor: 4.033

Review 7.  Up to date knowledge on different treatment strategies for phenylketonuria.

Authors:  Amaya Bélanger-Quintana; Alberto Burlina; Cary O Harding; Ania C Muntau
Journal:  Mol Genet Metab       Date:  2011-08-16       Impact factor: 4.797

8.  Evaluation of orally administered PEGylated phenylalanine ammonia lyase in mice for the treatment of Phenylketonuria.

Authors:  Christineh N Sarkissian; Tse Siang Kang; Alejandra Gámez; Charles R Scriver; Raymond C Stevens
Journal:  Mol Genet Metab       Date:  2011-06-29       Impact factor: 4.797

9.  Molecular cloning of the phenylalanine ammonia lyase gene from Rhodosporidium toruloides in Escherichia coli K-12.

Authors:  H J Gilbert; I N Clarke; R K Gibson; J R Stephenson; M Tully
Journal:  J Bacteriol       Date:  1985-01       Impact factor: 3.490

10.  Converting an injectable protein therapeutic into an oral form: phenylalanine ammonia lyase for phenylketonuria.

Authors:  Tse Siang Kang; Lin Wang; Christineh N Sarkissian; Alejandra Gámez; Charles R Scriver; Raymond C Stevens
Journal:  Mol Genet Metab       Date:  2010-01       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.